Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-048129
Filing Date
2015-05-29
Accepted
2015-05-29 21:10:21
Documents
1
Period of Report
2015-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4373
  Complete submission text file 0001209191-15-048129.txt   5598
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
CHAPLIN DAVID (Reporting) CIK: 0001167232 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 15901100